TMDX241220C50000
- 24.20
- -2.80-10.37%
TransMedics Newsroom
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $110
Sector Update: Health Care Stocks Higher Tuesday Afternoon
Why TransMedics Stock Plummeted Today
Update: TransMedics Names Gerardo Hernandez as CFO; Shares Fall
Behind the Scenes of TransMedics Gr's Latest Options Trends
Express News | Oppenheimer Maintains Outperform on TransMedics Gr, Maintains $125 Price Target
TransMedics Ushers In New CFO, Tightens 2024 Revenue Goals
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $104 to $120
Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics, Inc. (APGE) and TransMedics Group (TMDX)
Express News | Transmedics Group Shares Down 8% Premarket After Co Tightens FY Revenue Forecast Range
Express News | Needham Reiterates Hold on TransMedics Grto Hold
TransMedics Gr Analyst Ratings
Biggest Stock Movers Tuesday: ZS, SMCI, and More
TransMedics' Positive Trajectory: Buy Rating Reinforced by Growth in Heart and Lung Transplants
Stocks to Watch: Zscaler, Janux Therapeutics, TransMedics
TransMedics Names Gerardo Hernandez as CFO; Updates Full Year 2024 Guidance
TransMedics Stock Plunges 10% on Updated Guidance After Naming New CFO
Trending Stocks Today | Volato Group Soars 90.48% Post-Market
TransMedics Group Shares Are Trading Lower After the Company Issued Worse-than-expected FY24 Revenue Guidance.